Global Trends and Concerns in Weight Loss Medications
Groundbreaking diabetes and weight loss drugs like Ozempic, Mounjaro, and Wegovy offer significant benefits but vary greatly in cost worldwide, with the US being the most expensive and countries like India and the UK offering more affordable options. Patent expirations are expected to reduce prices further, potentially increasing access, but affordability remains dependent on local policies, insurance, and manufacturing factors.